Using MR Enterography and CT Enterography for Routine Crohn's Surveillance: How We Do It Now, and How We Hope to Do it in the Future.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Visual theranostic oral nanozymes for IBD from principles to preclinical design.Bioactive materials · 2026
   Review
2. The Current Role of Imaging in the Diagnosis of Inflammatory Bowel Disease and Detection of Its Complications: A Systematic Review.Cureus · 2024
   Review
3. Looking Back at 2022 and ahead to 2023 for theKorean journal of radiology · 2023
   Article
4. Is radiological healing alone enough? 'Can't take my eyes off' the mucosa.The Korean journal of internal medicine · 2022
   Article
5. CT or MR Enterography to Assess Response During Vedolizumab Therapy for Small Bowel Crohn's Disease.Crohn's & colitis 360 · 2022
   Article

Corrections and comments

• Comment on
  Is the Mixed Use of Magnetic Resonance Enterography and Computed Tomography Enterography Adequate for Routine Periodic Follow-Up of Bowel Inflammation in Patients with Crohn's Disease?2022

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as